Skip to content
ppharmaranks
Menu
Class ITerminated

Ascorbic Acid Inj. Solution recall

FDA recall D-0040-2025 · initiated Sep 30, 2024

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Nov 13, 2024How we research

Staska Pharmaceuticals, Inc. recalled Ascorbic Acid Inj. Solution in Sep 2024 — an FDA Class I recall (D-0040-2025) because Presence of Particulate Matter: Presence of glass particulates.

Most serious — a reasonable probability that use will cause serious harm or death.

Why it was recalled

Presence of Particulate Matter: Presence of glass particulates.

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #SP2400058, Exp 12/31/2024

Quantity recalled: 4773 vials

Details

Product
Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317
Recalling company
Staska Pharmaceuticals, Inc.
Classification
Class I
Status
Terminated
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Sep 30, 2024
FDA report date
Nov 13, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Ascorbic Acid Inj. Solution recalled?
Staska Pharmaceuticals, Inc. recalled Ascorbic Acid Inj. Solution in Sep 2024 — an FDA Class I recall (D-0040-2025) because Presence of Particulate Matter: Presence of glass particulates. Most serious — a reasonable probability that use will cause serious harm or death.
Why was Ascorbic Acid Inj. Solution recalled?
Per the FDA enforcement record, the reason for recall D-0040-2025 was: Presence of Particulate Matter: Presence of glass particulates.
Is a recalled Ascorbic Acid Inj. Solution dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Ascorbic Acid Inj. Solution are affected?
Distributed: Nationwide in the USA. The recall covers these lots — Lot #SP2400058, Exp 12/31/2024. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0040-2025.

Source: openFDA Drug Enforcement record D-0040-2025

← All drug recalls